British High Commissioner to Bangladesh Robert Chatterton Dickson on Wednesday said the Oxford vaccine would be accessible in Bangladesh once it is developed and prepared for use.
He, however, said there will be no clinical trial of the British vaccine in Bangladesh right now.
British Prime Minister Boris Johnson, in his UNGA discourse, said the Oxford vaccine is presently in stage 3 of clinical trials, and on account of progress AstraZeneca has just started to manufacture millions of doses, in readiness for rapid distribution.
They have reached an agreement with the Serum Institute of India to supply one billion doses to low and middle-income countries.
The UK is giving importance to equal access to vaccines by all the countries.
The British High Commissioner said the UK remains beside Bangladesh in addressing climate-related challenges and helping to resolve the Rohingya crisis apart from deepening trade and investment relations with Bangladesh.
High Commissioner Dickson made the remarks at DCAB Talks held virtually.
Dickson said he sees an energizing time in Bangladesh-UK relations. “We’re seeing a ton of enthusiasm for British businesses and in the government (to enhance trade relations).
He said the UK gives exceptionally excellent products and services in Bangladesh.
Dickson said they are chipping away at certain projects as Bangladesh praises 50 years of autonomy, and 50 years of wonderful advancement as an autonomous nation one year from now.
He said he is generally empowered by the exchange connection between the two nations. “We’re now Bangladesh’s second-largest investor, and we’ve all out two-sided exchange of around £4 billion per year.”
Photo credit: Collected
